MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

target price 22 cents, page-19

  1. 1,401 Posts.
    lightbulb Created with Sketch. 1
    re: sp prices relative to the market MBP still have a few products to be undergo trial this coming months.
    Anyway Pat and Syring thanks for your advices but Iam still hold.
    For me you have to show alot of patients with biotec company. (Cochlear drop down from $36 to $18.5c in 9/3-1/4).
    ABM AMRO sentiment is hold.(Last monthe Financial review paper)
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.